Vildagliptin and its role in the treatment of diabetes mellitus
Type 2 diabetes mellitus is a most serious medical problem throughout the world. Traditional hypoglycemic agents do not ensure long-term control ofglycemia and fail to affect the natural course of DM. An ideal hypoglycemic medicine must be efficacious, safe, and convenient to use for the preventiono...
Main Author: | Yury Shavkatovich Khalimov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2010-09-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5495 |
Similar Items
-
Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
by: Alexander Sergeevich Ametov, et al.
Published: (2010-06-01) -
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014-03-01) -
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2009-06-01) -
New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-12-01) -
Management of type 2 diabetes mellitus: selecting the right of antihyperglycemic medication
by: E. V. Biryukova
Published: (2018-03-01)